Herbert Cubasch
Overview
Explore the profile of Herbert Cubasch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dubner J, Neugut A, Joffe M, ONeil D, Ayeni O, Chen W, et al.
Lancet Glob Health
. 2024 Nov;
12(12):e1993-e2002.
PMID: 39577973
Background: Breast cancer is the most common malignancy diagnosed among women in South Africa, with the aggressive triple-negative subtype comprising approximately 15% of breast cancers in this population. South Africa...
2.
Kim J, Macharia P, McCormack V, Foerster M, Galukande M, Joffe M, et al.
Lancet Glob Health
. 2024 May;
12(7):e1111-e1119.
PMID: 38788756
Background: There is an urgent need to improve breast cancer survival in sub-Saharan Africa. Geospatial barriers delay diagnosis and treatment, but their effect on survival in these settings is not...
3.
Mapanga W, Ayeni O, Chen W, Jacobson J, Neugut A, Ruff P, et al.
PLOS Glob Public Health
. 2023 Oct;
3(10):e0002432.
PMID: 37874786
The South African Breast Cancer and HIV Outcomes prospective cohort (SABCHO) study was established to investigate survival determinants among HIV-positive and HIV-negative SA women with breast cancer. This paper describes...
4.
Dix-Peek T, Dickens C, Augustine T, Phakathi B, Van Den Berg E, Joffe M, et al.
Mol Med Rep
. 2023 Oct;
28(6).
PMID: 37830168
Black African populations are more genetically diverse than others, but genetic variants have been studied primarily in European populations. The present study examined the association of four single nucleotide polymorphisms...
5.
Joffe M, Ayeni O, Mapanga W, Ruff P, Murugan N, Cubasch H, et al.
Glob Health Action
. 2023 Jul;
16(1):2228567.
PMID: 37431748
There is a rising noncommunicable disease (NCD) burden in low- and middle-income countries. Sub-Saharan Africa (SSA) bears a higher burden than the global average with South Africa (SA) enduring the...
6.
Phakathi B, Dix-Peek T, Van Den Berg E, Dickens C, Nietz S, Cubasch H, et al.
Breast Cancer Res Treat
. 2023 Jun;
200(3):337-346.
PMID: 37266756
Purpose: Treatment decision making for patients with breast cancer increasingly depends on analysis of markers or systems for estimating risk of breast cancer recurrence. Breast cancer intrinsic subtypes and risk...
7.
Chasimpha S, Dos Santos Silva I, Martei Y, Grover S, Cubasch H, McCormack V
JCO Glob Oncol
. 2023 Apr;
9:e2200330.
PMID: 37075268
No abstract available.
8.
Chiwambutsa S, Ayeni O, Kapungu N, Kanji C, Thelingwani R, Chen W, et al.
Clin Pharmacol Ther
. 2023 Apr;
114(1):127-136.
PMID: 37042388
Clinical outcomes of tamoxifen (TAM) treatment show wide interindividual variability. Comedications and genetic polymorphisms of enzymes involved in TAM metabolism contributes to this variability. Drug-drug and drug-gene interactions have seldom...
9.
ONeil D, Ayeni O, Farrow H, Chen W, Demetriou G, Buccimazza I, et al.
Oncologist
. 2023 Mar;
28(10):e921-e929.
PMID: 36943395
Introduction: In the South African Breast Cancer and HIV Outcomes (SABCHO) study, we previously found that breast cancer patients living with HIV and treated with neoadjuvant chemotherapy achieve lower rates...
10.
Dix-Peek T, Phakathi B, Van Den Berg E, Dickens C, Augustine T, Cubasch H, et al.
Breast Cancer Res Treat
. 2023 Mar;
199(1):1-12.
PMID: 36867282
Purpose: Breast cancer is a heterogeneous disease with different gene expression profiles, treatment options and outcomes. In South Africa, tumors are classified using immunohistochemistry. In high-income countries multiparameter genomic assays...